Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

NCT02262637 · clinicaltrials.gov ↗

COMPLETED

Status

4814

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Micardis®
DRUG: MicardisPlus®

Sponsor

Boehringer Ingelheim